Furthermore, compared with the absent treatment of berberine, the treatment with berberine significantly increases radiosensitivity in ESCC by blocking VEGF and HIF-1α, which can be clinically applied to radiotherapy resistance [37]. Here, HIF1A is linked to esophageal squamous cell carcinoma.